Dr. Ghali is board-certified in internal medicine and cardiovascular medicine. As principal investigator, Dr. Ghali has conducted over 200 clinical trials predominantly in heart failure and has contributed to the medical literature more than 200 publications, predominantly in the field of heart failure. He has been serving on the editorial board of several prominent journals such as the American Heart Journal, the European Journal of Heart Failure, the Journal of the American College of Cardiology Heart Failure, and the American Journal of Cardiology. He has served as a member of several steering committees, adjudication committees, and data and safety monitoring boards in various heart failure trials. He has served as Chief of Cardiology at DMC Detroit Receiving Hospital in Detroit and Mercer University in Macon.
Jalal K. Ghali, MD
- Cardiovascular Disease
- ABMS Internal Medicine
- Mount Sinai Hospital
Education & Training
- Medical School: Damascus University Medical School
- Internship: Cook County Hospital
- Residency: Mount Sinai Hospital
Cooper R, Sempos C, Ghali J, Ferlinz J. High Density Lipoprotein-Cholesterol and Angiographic Artery Disease in Blacks. Am Heart J 1985:110:1006-11.
Ghali J, Shanes J.A Review of Dilated Cardiomyopathy. ComprehensiveTherapy 1987;13(8):46-56.
Shanes J, Ghali J. Endomyocardial Biopsy Results. Cardiology Board Review 1987;4(9):112-21
Shanes J, Ghali J, Billingham M, Ferrans V, Fenoglio J, Edwards W, Tsai C, Saffitz J, Isner J, Furner S, Subramanian R. Interobserver Variability in the Pathologic Diagnosis of Endomyocardial Biopsy Results. Circulation 1987:74(2):401-5.
Simmons B, Castaner A, Santhanam V, Ghali J, Silverman N, Goldfaden D, Levitsky S, Cooper R, Ferlinz J. Outcome of Coronary Artery Bypass Grafting in Black Persons. Am J Cardiol 1987;59:547-51.
Lang RM, Borow KM, Neumann A, Newmann A, Carroll JD, Weinert L, Murphy MB, Ghali J, Rajfer SI. Role of the Beta2 Adrenoceptor in Mediating Positive Inotropic Activity in the Failing Heart and Its Relation to the Hemodynamic Actions of Dopexamine Hydrochloride. Am J Cardiol 1988;62:46C-52C.